{
  "topic": "sepsis_treatment_plan",
  "pmid": "41180093",
  "pdf_path": "Annane_Sepsis_Corpus\\papers\\PMID_41180093\\paper.pdf",
  "source_url": "http://europepmc.org/backend/ptpmcrender.fcgi?accid=PMC12572860&blobtype=pdf",
  "sectionizer": "pdfplumber",
  "meta": {
    "pmid": "41180093",
    "title": "Corticosteroids in sepsis.",
    "journal": "J Intensive Med",
    "year": "2025",
    "authors": [
      "Mahmoud J",
      "Bovy MA",
      "Heming N",
      "Annane D"
    ],
    "doi": "10.1016/j.jointm.2025.08.006"
  },
  "sections": {
    "Abstract": "Journal of Intensive Medicine 5 (2025) 304â€“312 Contents lists available at ScienceDirect Journal of Intensive Medicine journal homepage: www.elsevier.com/locate/jointm Review Corticosteroids in sepsis Jihene Mahmoud 1, Marie Alice Bovy 1, Nicholas Heming 1 ,2 ,3 , Djillali Annane 1 ,2 ,3 ,âˆ— 1 Department of Intensive Care, Raymond PoincarÃ©Hospital, APHP University Versailles Saint Quentinâ€“University Paris Saclay, Garches, France 2 Institut Hospitalo Universitaire IHU-3 SEPSIS Institute, Garches, France 3 Laboratory of Infection & Inflammationâ€“U1173, School of Medicine, INSERM, University Versailles Saint Quentinâ€“University Paris Saclay, Garches, France a r t i c l e i n f o a b s t r a c t Managing Editor: Jingling Bao/Zhiyu Wang Sepsis is a major health and socioeconomic burden worldwide. Although international guidelines have helped reduce crude mortality rates from sepsis by optimizing infection control and support of vital organ function, Keywords: Molecular biology there are still no specific therapies for sepsis, other than corticosteroids. The aims of this narrative review were Pharmacology to provide readers with the most recent data on corticosteroids, as well as up-to-date evidence regarding their Preclinical models effects in patients with sepsis. Corticosteroids regulate the function of most cell types involved in host response Clinical trials to infections, through both genomic and non-genomic effects, reprogramming immune cells (via regulation of Systematic reviews mitochondrial metabolism) toward anti-inflammatory types, restoring endothelial cell function and endothelium Guidelines integrity, facilitating epithelium repair, and restoring vascular smooth muscle function, as well as organ perfusion. In patients with sepsis, these effects are achieved using supraphysiological doses of corticosteroids, equating to approximately 200 mg/day of hydrocortisone equivalent for 5â€“15 days, depending on the clinical context. The molecular and cellular effects of corticosteroids translate into prevention and reversal of the need for vasopressor, respiratory, and renal supportive therapies, as well as acceleration of organ function resolution, shorter intensive care unit (ICU) and hospital stays, and improved short- and mid-term survival. Remaining gaps in knowledge and evidence to inform practice include insufficient data about the effects of corticosteroids in children, a lack of reliable biomarkers to distinguish those patients who can benefit from treatment, and inadequate information about the effects of corticosteroids on the long-term sequelae of sepsis. The Burden of Sepsis ter sepsis develop new health problems, with annual costs of â‚¬6.8 billion.[ 5 ] In 2017, almost half of all sepsis cases globally The social, economic, and health burdens of sepsis, which occurred in children, with approximately 20 million cases and is defined as life-threatening organ dysfunction triggered by 2.9 million deaths in children aged < 5 years. Analysis of the an abnormal host response to invading microorganisms,[ 1 ] are 2016 Kidsâ€™ Inpatient Database (KID) dataset in the US iden- heavy worldwide. Among organisms that cause sepsis, Strepto- tified 12,297 patients of 0â€“21 years old with sepsis admitted coccus pneumoniae, Streptococcus aureus, Escherichia coli, Kleb- to 1253 hospitals, and determined a crude mortality rate of siella pneumoniae , and Pseudomonas aeruginosa account for more 14.6 %.[ 6 ] Risk of death differed according to patient ethnic- than two-thirds of cases, and there is a high prevalence of mul- ity, geographic region, and insurance status.[ 7 ] At 12 months tidrug resistance.[ 2 , 3 ] Although sepsis is a major threat to EU following pediatric intensive care unit (ICU) admission for sep- and US populations, it disproportionally affects the most vul- tic shock, 13 % of patients had died, and 35 % of surviving pa- nerable and low- and middle-income populations, with approx- tients had not regained their previous quality of life.[ 8 ] In the imately 50 (3.4 in EU) million cases and 11 (0.68 in EU) mil- European Union Childhood Life-threatening Infectious Disease lion deaths annually.[ 4 ] Given population growth and aging, Study (EUCLIDS) study of 2844 patients aged 1 month to 18 cases of sepsis are predicted to double by 2050.[ 2 ] Furthermore, years, the main sources of sepsis were pneumonia (18 %), cen- around three-quarters of patients who survive for 3 years af- tral nervous system (17 %), and soft tissue infection (9 %), and âˆ— Corresponding author: Djillali Annane, Sepsis Institute, Department of Intensive Care Medicine, Raymond PoincarÃ©Hospital, APHP University Versailles Saint Quentinâ€“University Paris Saclay; General Intensive Care Unit, Raymond PoincarÃ©Hospital (APHP), UniversitÃ©Paris Saclay-UVSQ, 104, Boulevard Raymond PoincarÃ© 92380, Garches, France E-mail address: djillali.annane@aphp.fr (D. Annane) . https://doi.org/10.1016/j.jointm.2025.08.006 Received 20 June 2025; Received in revised form 20 July 2025; Accepted 12 August 2025 Available online 19 September 2025 Copyright Â©2025 The Author(s). Published by Elsevier B.V. on behalf of Chinese Medical Association. This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ) J.Mahmoud,M.A.Bovy,N.Hemingetal. JournalofIntensiveMedicine5(2025)304â€“312 causal microorganisms included Neisseria meningitidis (9 %), S. receptor signaling in mast cells, macrophages, basophils, and aureus (8 %), S. pneumoniae (8 %), and group A streptococcus eosinophils; (2) increasing histamine release from mast cells; (6 %).[ 9 ] In 2017, the World Health Organization urged state (3) polarization of macrophages toward type 2, with decreased members to act. Evidence-based guidelines,[ 10 ] including early proinflammatory cytokine production, increased release of anti- source control, antimicrobials, and vital organ function support, inflammatory molecules, and elevated phagocytosis activity; (4) have contributed to a reduction in sepsis mortality.[ 11 ] With the increasing neutrophil production; and (5) increasing apoptosis exception of corticotherapy in patients with septic shock,[ 12 , 13 ] of basophils and eosinophils. Glucocorticoids also increase nat- no specific interventions are available for sepsis.[ 10 , 14 ] Hyper- ural killer cell activation and dendritic cell apoptosis, while in- and hypo-inflammation are concurrent, sustained, and vary ac- hibiting their maturation and capacity to produce proinflamma- cording to pathogen and host characteristics.[ 15 , 16 ] Key chal- tory cytokines and present antigen. lenges include the provision of dynamic characterization (pre- The role of glucocorticoids in immune cell metabolism has re- diction) of individual risks and response to treatments (treatable cently been unraveled.[ 29 , 30 ] Glucocorticoids reprogram inflam- traits).[ 17 , 18 ] matory macrophages into anti-inflammatory cells by modulat- ing mitochondrial function, inhibiting glycolysis and hypoxia- induced factor 1 alpha, and stimulating itaconate, which coun- The Pharmacological Basis of Corticotherapy for Sepsis teracts succinate accumulation resulting from stalling of the tri- carboxylic acid cycle. The effects of glucocorticoids in restoring A recent review has summarized 75 years of discoveries about the molecular mechanisms of action of corticosteroids.[ 19 ] the mitochondrial network are GR-dependent and mainly non- genomic via GR interaction with pyruvate dehydrogenase.[ 31 ] Corticosteroids act via their receptors: glucocorticoid receptor (GR), encoded by the NR3C1 gene, and mineralocorticoid re- ceptor (MR), encoded by NR3C2 . While GR is present in al- Preclinical Evidence for Corticosteroid Use in Sepsis most all cells, MR only binds glucocorticoids in kidney and brain.[ 19 ] Inactive GR resides in the cytoplasm, stabilized by In various animal models (rabbits and dogs), structural chaperone proteins, while the glucocorticoidâ€“GR complex traps smooth muscle alterations that cause decreased vasomotor tone nuclear factor-kappaB (NF- ðœ…B) in the cytoplasm, preventing are fully reversed by dexamethasone, with subsequent restora- its nuclear translocation. The main active GR isoform, GR al- tion of norepinephrine contractility.[ 32 ] These beneficial effects pha, comprises 777 amino acids with the following domains: of dexamethasone vary according to its pharmacological for- an N-terminal transactivation domain, activation domain 1, a mulation, with disodium phosphate ester having substantial ef- DNA-binding domain, and a ligand-binding domain, and acti- fects, while sodium sulfate ester was ineffective.[ 33 ] Methyl- vation domain 2. After translocation to the nucleus, activated prednisolone is also reported to have cardiovascular protective GR proceeds through a stepwise process, starting from binding effects in primates challenged with intravenous endotoxin.[ 34 ] to DNA at GR binding sites, followed by recruitment of coreg- Furthermore, the protective cardiovascular effects of corticos- ulators (including nuclear receptor coactivators 1â€“3 and nu- teroids have been demonstrated at the regional circulation level clear receptor corepressors 1â€“2). Next, GR monomers inhibit the in the liver,[ 35 , 36 ] gut,[ 37 ] brain,[ 38 ] lung,[ 39 ] and kidney.[ 40 ] The proinflammatory transcription factors, NF- ðœ…B and AP1, thereby mechanisms underlying the cardiovascular protection exerted repressing expression of their downstream genes (transrepres- by corticosteroids include: (1) facilitation of neuronal excitabil- sion), while GR dimers binds to glucocorticoid responsive ele- ity, with enhancement of central sympathetic outflow;[ 41 ] (2) ments (GRE) to induce (transactivate) or negative GRE to inhibit decreased in sepsis-induced vascular permeability[ 42 , 43 ] (3) in- gene expression. There are also other GR monomer binding sites, hibition of nitric oxide synthase,[ 44 ] group II secretory phos- and tetrameric GR complexes can also bring two glucocorticoid pholipase A2,[ 45 ] cyclooxygenase metabolites,[ 46 ] endothelin- binding sites together.[ 20 , 21 ] Beyond the transrepression through 1,[ 47 ] ATP-sensitive potassium channels,[ 48 ] and NF- ðœ…B;[ 49 ] and GR monomers and transactivation by GR dimers, activated GR (4) upregulation of adrenomedullin,[ 50 ] the RhoA/ RhoA kinase also upregulates the Dusp1,[ 22 ] Anxa1,[ 23 ] Gilz,[ 24 ] and A20[ 25 ] (ROCK), extracellular signal â€‘regulated kinase (ERK), and p38 anti-inflammatory genes. signaling pathways,[ 51 ] and norepinephrine-induced shrinkage Glucocorticoids also have rapid non-genomic effects, result- and actin cytoskeleton rearrangement.[ 52 ] ing from their interactions with membrane sites, the chaperone Preclinical evidence for attenuation of inflammation in sepsis proteins that are released when glucocorticoids bind to GR, or by corticosteroids is also abundant.[ 53â€“56 ] Methylprednisolone from phosphoinositide 3-kinase competition.[ 26 ] can restore phagocytic and opsonin activities in the reticuloen- The main effects of corticosteroids relevant to their appli- dothelial system.[ 53 ] Furthermore, glucocorticoids preserve neu- cation in patients with sepsis are summarized in Table 1 . The trophil function in dogs with E. coli sepsis,[ 54 ] inhibit the release molecular effects of corticosteroids are cell-type specific.[ 27 ] At and lethality of tumor necrosis factor and IL-1 in mice,[ 55 ] re- the level of adaptive immunity, glucocorticoids inhibit polariza- duce Kupffer cells (a major source of cytokines in sepsis),[ 56 ] tion toward T helper (TH) 1 and TH17 cells and correspond- lower plasma hydrogen sulfide concentration,[ 57 ] prevent and ing proinflammatory cytokines, while increasing polarization reverse NF- ðœ…B expression,[ 58 ] reduce mitochondrial injury, but toward TH2 cells.[ 28 ] Furthermore, they increase apoptosis a",
    "Method": "",
    "Conclusion": ""
  }
}